- Home
- AGL vs CYRX Comparison
AGL vs CYRX Comparison
Compare AGL & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGL | CYRX |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 419.3M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AGL | CYRX |
|---|---|---|
| Price | $22.68 | $9.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $64.25 | $12.94 |
| AVG Volume (30 Days) | ★ 2.4M | 406.1K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | ★ $5,932,576,000.00 | $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $4.30 | $8.45 |
| P/E Ratio | ★ N/A | $6.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.30 | $5.21 |
| 52 Week High | $21.91 | $11.45 |
Technical Indicators
Market Signals| Indicator | AGL | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 94.44 | 70.69 |
| Support Level | $0.63 | $9.18 |
| Resistance Level | N/A | $10.23 |
| Average True Range (ATR) | 1.81 | 0.42 |
| MACD | 1.73 | 0.19 |
| Stochastic Oscillator | 95.43 | 88.01 |
Price Performance
Historical ComparisonAbout AGL agilon health inc.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.